FTXH

First Trust Nasdaq Pharmaceuticals ETF
N/A

N/A
  • Overview
  • Efficiency
  • Tradability
  • Fit

FTXH Fund Description

The First Trust NASDAQ Pharmaceutical ETF tracks the most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

FTXH Factset Analytics Insight

The First Trust NASDAQ Pharmaceutical ETF tracks an index of highly liquid pharmaceutical stocks weighted according to various factors. While many funds perform a basic liquidity screen as part of their index construction and rebalancing, FTXH is noteworthy because it goes beyond the basic screen and uses liquidity selection. The 30 most liquid pharmaceutical stocks in the U.S are chosen for inclusion in the index as determined by the average daily traded volume over three months. The securities are then ranked and weighed according to value, volatility, and growth factors. Value is measured using a cash flow to price metric. The trailing one- year volatility provides another factor. Growth is considered using the average of the three- month, six- month, nine- month, and twelve- month price return.. FTXH’s expense ratio is higher than comparable funds in this segment.

FTXH MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of February 22, 2018 the First Trust Nasdaq Pharmaceuticals ETF MSCI ESG Fund Quality Score is 4.60 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. FTXH ranks in the 42nd percentile within its peer group and in the 21st percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

FTXH Top 10 Countries

FTXH Top 10 Sectors

FTXH Top 10 Holdings View All

FTXH Summary Data

First Trust
09/20/16
Open-Ended Fund
0.60%
$2.18M
$43.32K
0.63%

FTXH Portfolio Data

$87.27B
-11.66
3.56
2.16%
03/21/18
29

FTXH Index Data

Multi-Factor
Liquidity
Thomson Reuters US Pharmaceuticals

Related ETFs to FTXH

IHE, XPH, PJP
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

FTXH Portfolio Management

0.60%
--
--
--

FTXH Tax Exposures

20.00% / 39.60%
0.95%
Qualified dividends
No

FTXH Fund Structure

Open-Ended Fund
No
No
100% / 0%
N/A
N/A
High
Daily
Bats Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

FTXH Factset Analytics Block Liquidity

As of 02/23/18
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of FTXH. FTXH is rated a 4 out of 5.

FTXH Tradability

1,799
$43.32K
1,207
$29.39K
0.63%
$0.14
0.06%
2.18% / -3.04%
None
100.00%
50,000
0.02
0.05%
0.06%
--
$21.64
4

FTXH Sector/Industry BreakdownView All

FTXHSegment Benchmark
88.23% 82.36%

FTXH Geographic Exposure

FTXHSegment Benchmark
100.00% 101.62%

FTXHSegment Benchmark
100.00% 101.62%
0.00% / 0.00% 0.00% / 0.00%

FTXH Performance Statistics

0.65
1.01
0.90
1.03
0.54%
Thomson Reuters US Pharmaceuticals

FTXH MSCI ESG Ratings

4.60 / 10
41.80
20.52
--
12.88%
37.38

FTXH BENCHMARK COMPARISON

    FTXH
    29 Holdings
    Segment Benchmark
    49 Constituents
    Shared Holdings
    21 (Count)
     
    49.85% (Weight)
FTXHSegment Benchmark
180.76 B 87.27 B
96.53% 59.09%
1.75% 14.25%
1.59% 22.78%
0.13% 3.89%
37.52 -11.66
2.22% 1.25%